Ms Elisabeth Smits
Pharmo Institute, Utrecht (Netherlands (The))
Bleeding risk and healthcare resource utilisation in elderly patients treated with edoxaban or vitamin K antagonists for atrial fibrillation in Italy
Event: EHRA 2021
Topic: Treatment
Session: Optimal therapy of atrial fibrillation
Stroke associated with non-adherence and non-persistence with direct oral anticoagulants in Germany
Event: EHRA 2021
Topic: Treatment
Session: ePoster session
ESC 365 is supported by
